Quarterly Transactions Made in Voyager Therapeutics, Inc. (VYGR)
This table provides information about the institutional ownership of Voyager Therapeutics, Inc. (VYGR). The information is specifically focused on institutions that hold shares of Voyager Therapeutics, Inc..
Shares Purchased
Shares Sold
Quarter | Buy | Sell | Net Activity | |||||
---|---|---|---|---|---|---|---|---|
New Holding | Increment | Total Shares Bought | Closed Position | Reduction | Total Shares Sold | |||
Q3 2021 | 605,149 | 2,106,033 | 2,711,182 | 1,382,403 | 549,212 | 1,931,615 | 779,567 | |
Q4 2021 | 4,147,384 | 413,906 | 4,561,290 | 3,048,677 | 5,029,982 | 8,078,659 | -3,517,369 | |
Q1 2022 | 2,435,019 | 3,194,409 | 5,629,428 | 1,471,659 | 84,511 | 1,556,170 | 4,073,258 | |
Q2 2022 | 4,852,842 | 656,750 | 5,509,592 | 1,816,365 | 1,053,614 | 2,869,979 | 2,639,613 | |
Q3 2022 | 1,776,686 | 516,990 | 2,293,676 | 1,779,312 | 34,673 | 1,813,985 | 479,691 | |
Q4 2022 | 656,634 | 445,271 | 1,101,905 | 358,618 | 0 | 358,618 | 743,287 | |
Q1 2023 | 2,199,600 | 1,554,021 | 3,753,621 | 3,439,955 | 0 | 3,439,955 | 313,666 | |
Q2 2023 | 6,408,664 | 2,280,408 | 8,689,072 | 2,084,569 | 0 | 2,084,569 | 6,604,503 | |
Q3 2023 | 1,788,328 | 2,562,896 | 4,351,224 | 2,311,242 | 0 | 2,311,242 | 2,039,982 | |
Q4 2023 | 1,235,785 | 2,509,708 | 3,745,493 | 1,665,064 | 0 | 1,665,064 | 2,080,429 | |
Q1 2024 | 7,671,218 | 1,917,653 | 9,588,871 | 924,307 | 0 | 924,307 | 8,664,564 | |
Q2 2024 | 3,261,301 | 2,237,627 | 5,498,928 | 1,948,029 | 0 | 1,948,029 | 3,550,899 | |
Q3 2024 | 1,379,921 | 1,524,197 | 2,904,118 | 3,965,164 | 0 | 3,965,164 | -1,061,046 |